S&P 500   3,145.91 (+0.91%)
DOW   28,015.06 (+1.22%)
QQQ   205.00 (+1.07%)
AAPL   270.71 (+1.93%)
FB   201.05 (+0.85%)
MSFT   151.75 (+1.21%)
GOOGL   1,339.39 (+0.94%)
AMZN   1,751.60 (+0.64%)
CGC   18.65 (+0.27%)
NVDA   212.17 (+1.64%)
MU   47.93 (+2.81%)
BABA   201.89 (+0.95%)
GE   11.10 (+2.87%)
TSLA   335.89 (+1.67%)
T   38.20 (+0.03%)
AMD   39.63 (+0.03%)
ACB   2.43 (-0.41%)
F   9.02 (+1.01%)
PRI   135.68 (+1.03%)
NFLX   307.35 (+1.48%)
BAC   33.67 (+1.75%)
GILD   67.08 (+1.74%)
DIS   147.66 (+0.15%)
S&P 500   3,145.91 (+0.91%)
DOW   28,015.06 (+1.22%)
QQQ   205.00 (+1.07%)
AAPL   270.71 (+1.93%)
FB   201.05 (+0.85%)
MSFT   151.75 (+1.21%)
GOOGL   1,339.39 (+0.94%)
AMZN   1,751.60 (+0.64%)
CGC   18.65 (+0.27%)
NVDA   212.17 (+1.64%)
MU   47.93 (+2.81%)
BABA   201.89 (+0.95%)
GE   11.10 (+2.87%)
TSLA   335.89 (+1.67%)
T   38.20 (+0.03%)
AMD   39.63 (+0.03%)
ACB   2.43 (-0.41%)
F   9.02 (+1.01%)
PRI   135.68 (+1.03%)
NFLX   307.35 (+1.48%)
BAC   33.67 (+1.75%)
GILD   67.08 (+1.74%)
DIS   147.66 (+0.15%)
S&P 500   3,145.91 (+0.91%)
DOW   28,015.06 (+1.22%)
QQQ   205.00 (+1.07%)
AAPL   270.71 (+1.93%)
FB   201.05 (+0.85%)
MSFT   151.75 (+1.21%)
GOOGL   1,339.39 (+0.94%)
AMZN   1,751.60 (+0.64%)
CGC   18.65 (+0.27%)
NVDA   212.17 (+1.64%)
MU   47.93 (+2.81%)
BABA   201.89 (+0.95%)
GE   11.10 (+2.87%)
TSLA   335.89 (+1.67%)
T   38.20 (+0.03%)
AMD   39.63 (+0.03%)
ACB   2.43 (-0.41%)
F   9.02 (+1.01%)
PRI   135.68 (+1.03%)
NFLX   307.35 (+1.48%)
BAC   33.67 (+1.75%)
GILD   67.08 (+1.74%)
DIS   147.66 (+0.15%)
S&P 500   3,145.91 (+0.91%)
DOW   28,015.06 (+1.22%)
QQQ   205.00 (+1.07%)
AAPL   270.71 (+1.93%)
FB   201.05 (+0.85%)
MSFT   151.75 (+1.21%)
GOOGL   1,339.39 (+0.94%)
AMZN   1,751.60 (+0.64%)
CGC   18.65 (+0.27%)
NVDA   212.17 (+1.64%)
MU   47.93 (+2.81%)
BABA   201.89 (+0.95%)
GE   11.10 (+2.87%)
TSLA   335.89 (+1.67%)
T   38.20 (+0.03%)
AMD   39.63 (+0.03%)
ACB   2.43 (-0.41%)
F   9.02 (+1.01%)
PRI   135.68 (+1.03%)
NFLX   307.35 (+1.48%)
BAC   33.67 (+1.75%)
GILD   67.08 (+1.74%)
DIS   147.66 (+0.15%)
Log in

NASDAQ:SMTI - Sanara MedTech Stock Price, Forecast & News

$10.78
-0.22 (-2.00 %)
(As of 12/6/2019 04:00 PM ET)
Today's Range
$9.82
Now: $10.78
$11.00
50-Day Range N/A
52-Week Range
$2.00
Now: $10.78
$14.00
Volume4,685 shs
Average Volume2,057 shs
Market Capitalization$25.51 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Sanara MedTech Inc. develops, markets, and distributes biotechnology products to physicians, hospitals, and clinics in the United States. It offers HemaQuell, a resorbable bone hemostat for bone healing; and CellerateRX surgical for healing. The company was formerly known as WNDM Medical Inc. and changed its name to Sanara MedTech Inc. in May 2019. Sanara MedTech Inc. was founded in 1982 and is based in Fort Worth, Texas.

Industry, Sector and Symbol

Industry Medical Care
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:SMTI
CUSIPN/A
CIKN/A
Phone817-529-2300

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Employees19
Market Cap$25.51 million
Next Earnings Date2/13/2020 (Estimated)
OptionableNot Optionable

Receive SMTI News and Ratings via Email

Sign-up to receive the latest news and ratings for SMTI and its competitors with MarketBeat's FREE daily newsletter.


Sanara MedTech (NASDAQ:SMTI) Frequently Asked Questions

What is Sanara MedTech's stock symbol?

Sanara MedTech trades on the NASDAQ under the ticker symbol "SMTI."

When is Sanara MedTech's next earnings date?

Sanara MedTech is scheduled to release their next quarterly earnings announcement on Thursday, February 13th 2020. View Earnings Estimates for Sanara MedTech.

Has Sanara MedTech been receiving favorable news coverage?

Media stories about SMTI stock have trended somewhat negative on Friday, InfoTrie Sentiment Analysis reports. The research group identifies negative and positive media coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. Sanara MedTech earned a media sentiment score of -1.5 on InfoTrie's scale. They also gave press coverage about the company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an impact on the company's share price in the immediate future. View News Stories for Sanara MedTech.

Who are some of Sanara MedTech's key competitors?

What other stocks do shareholders of Sanara MedTech own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Sanara MedTech investors own include Vaso (VASO) and Plaintree Systems (PTEEF).

Who are Sanara MedTech's key executives?

Sanara MedTech's management team includes the folowing people:
  • Mr. J. Michael Carmena, Vice Chairman & Principal Exec. Officer (Age 63)
  • Mr. Michael D. McNeil, Chief Financial Officer (Age 53)
  • Mr. Ronald T. Nixon, Exec. Chairman (Age 63)
  • Mr. Callon Nichols, Director of Investor Relations
  • Dr. Jane A. Fore, Chief Medical Officer

How do I buy shares of Sanara MedTech?

Shares of SMTI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Sanara MedTech's stock price today?

One share of SMTI stock can currently be purchased for approximately $10.78.

How big of a company is Sanara MedTech?

Sanara MedTech has a market capitalization of $25.51 million. Sanara MedTech employs 19 workers across the globe.View Additional Information About Sanara MedTech.

What is Sanara MedTech's official website?

The official website for Sanara MedTech is http://www.wndm.com/.

How can I contact Sanara MedTech?

The company can be reached via phone at 817-529-2300.


MarketBeat Community Rating for Sanara MedTech (NASDAQ SMTI)

Community Ranking:  2.1 out of 5 (star star)
Outperform Votes:  3 (Vote Outperform)
Underperform Votes:  4 (Vote Underperform)
Total Votes:  7
MarketBeat's community ratings are surveys of what our community members think about Sanara MedTech and other stocks. Vote "Outperform" if you believe SMTI will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SMTI will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 12/6/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel